Theme: Ways in restoring vision from thief of sight
Glaucoma 2016
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
It is a condition that causes damage to eye’s optic nerve which could cause loss of vision permanently. One of the major reason of Glaucoma is due to the high intraocular pressure damaging the optic nerve which sends images to the brain. Glaucoma can affect both the eyes, but the extent of damage on each eye can be different.
Related Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences
International Conference and Expo on Cataract Conference and Refractive Surgery August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 9th Global Ophthalmology Summit November 28 - 30, 2016 Sao Paulo, Brazil; 10th International Conference on Clinical & Experimental Ophthalmology Conference Nov 28-30, 2016 Dubai, UAE; 6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology Conference (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; American Academy of Ophthalmology Conference October 15-18, Chicago 2016; World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016; 3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; National Glaucoma Symposium July 30-August 1, Brewster, MA, 2016.
Symptoms and Diagnosis of Glaucoma
Usually there are very few or no symptoms of glaucoma. However loss of peripheral or side vision would initially take place and eventually leading to the loss of central vision. Hereby early diagnosis of Glaucoma is very important which can be detected through a comprehensive dilated eye exam.
Releted Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences
7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 9th Global Ophthalmology Summit November 28 - 30, 2016 Sao Paulo, Brazil; 10th International Conference on Clinical & Experimental Ophthalmology Conference Nov 28-30, 2016 Dubai, UAE; 6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract Conference and Refractive Surgery August 04-05, 2016 Manchester, UK; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland; Future World Ophthalmology Congress of the International Council of Ophthalmology Conference 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; American Academy of Ophthalmology October 15-18, Chicago 2016; World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016;3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; National Glaucoma Symposium July 30-August 1, Brewster, MA, 2016.
Effectiveness of treatment depends upon the extent of glaucoma attack in an individual. Early diagnosis plays a major role in treating Glaucoma. Regular treatments can also treat glaucoma to save the remaining vision, however the damage caused is not irreversible.
Releted Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences
10th International Conference on Clinical & Experimental Ophthalmology Conference Nov 28-30, 2016 Dubai, UAE; 6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract Conference and Refractive Surgery August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 9th Global Ophthalmology Summit November 28 - 30, 2016 Sao Paulo, Brazil; Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland; American Academy of Ophthalmology October 15-18, Chicago 2016; World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016; 3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; National Glaucoma Symposium July 30-August 1, Brewster, MA, 2016.
Novel therapeutics ways for treating Glaucoma
The most important discovery in scientific research often come from an investigator with new idea. Discussion and gaining knowledge through various scientists would lead the Innovative research leading to cure with an affirmative result for the wellbeing of the society
Releted Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences
8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA;10th International Conference on Clinical & Experimental Ophthalmology Conference Nov 28-30, 2016 Dubai, UAE; 6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology Conference (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology Conference 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland; American Academy of Ophthalmology October 15-18, Chicago 2016; World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016;3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; National Glaucoma Symposium July 30-August 1, Brewster, MA, 2016.
Stem Cell Therapy Replacement for Retinal Ganglion Cells
Glaucoma is disease in the eye characterized by the progressive loss of retinal ganglion cells. Stem cell based therapeutics provide a method for restoration of neurons damaged by retinal disease. With the extensive research in the stem cells and its success rate, stem cells can differentiate into retinal neurons in vitro and in vivo following transplantation for retinal degeneration. With stem cell transplantation therapy which has been shown to preserve retinal integrity and attenuate the loss of retinal ganglion cell function when transplanted by using technology.
Releted Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences
International Conference and Expo on Cataract Conference and Refractive Surgery August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 9th Global Ophthalmology Summit November 28 - 30, 2016 Sao Paulo, Brazil; 10th International Conference on Clinical & Experimental Ophthalmology Conference Nov 28-30, 2016 Dubai, UAE; 6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology Conference (MEACO)4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; American Academy of Ophthalmology October 15-18, Chicago 2016; World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016;3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; National Glaucoma Symposium July 30-August 1, Brewster, MA, 2016.
Retinoblastoma is an eye cancer that begins in the retina — the sensitive lining on the inside of your eye. Retinoblastoma most commonly affects young children, but can rarely occur in adults. A rare form of eye cancer, retinoblastoma is the most common form of cancer affecting the eye in children which may affect one or both the eyes.
Releted Conferences: Glaucoma Conferences | Ophthalmology Conferences | Asia Pacific Ophthalmology Conferences
6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract Conference and Refractive Surgery August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 9th Global Ophthalmology Summit November 28 - 30, 2016 Sao Paulo, Brazil; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology Conference (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology Conference 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; American Academy of Ophthalmology October 15-18, Chicago 2016;World Ophthalmology Congress (WOC) Feb 5-9, Mexico 2016; 3rd Asia Pacific Glaucoma Congress July 14-16, Thailand 2016; 12th EGS Congress June 19-22, Prague, Czech Republic 2016; American Glaucoma Society March 3-6, Fort Lauderdale, FL 2016; ARVO 2016 Annual Meeting May 1-5, Washington 2016; Retina 2017, January 16-20, Grand Hyatt Kauai Poipu, Kauai; Hawaiian Eye 2016, January 16-20, Hawaii; Nationa lGlaucoma Symposium July 30-August 1, Brewster, MA, 2016.
Conference series LLC invites all participants across the world to join the Global Ophthalmology and Glaucoma Conference which is going to be held during October 13-15 at Kuala Lumpur, Malaysia following the theme of “Ways in restoring vision from thief of sight”. Glaucoma-2016 conference will concentrate on latest and exciting innovations in areas of treating glaucoma, diagnostics and recent technologies towards glaucoma treatment and prevention. Glaucoma-2016 also acts as a platform to exchange information, new interventions and strengthen the collaboration among Ophthalmologists, Researchers, Associate Professors, and Scholars from both academia and ophthalmic Institutes.
Conference series LLC Organizes 300+ conferences, 500+ workshops and 200+ symposiums on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Glaucoma is the major cause of blindness worldwide. With extensive research being carried out for early diagnosis and treatment of glaucoma can minimize and prevent optic nerve damage, therefore limiting or preventing vision loss. With the advancements in technology, treatment is highly effective, however damage caused by this disease cannot always be reversed – early detection is a key element to prevent vision loss. This three day event include the major sessions
Eye 2016 market research:
Glaucoma Treatment Market research : This glaucoma treatment market report covers provides data and information on The US and Japan under its country coverage. Glaucoma treatment forms a significant portion of the overall eye care market. The market for glaucoma treatment has grown rapidly in the last decade, based on both increasing number of people with glaucoma and the introduction of new treatments. However, the worldwide glaucoma treatment market is expected to decline that can be attributable to price reduction of drugs due to generic availability of many brands in coming years. For this glaucoma treatment market research, the glaucoma pharmaceuticals are segmented into two classes namely prostaglandins analogues (PGAs) and Non PGAs that include beta blockers, carbonic anhydrase inhibitors and alpha agonists. PGAS are the most widely prescribed drug class for glaucoma with latanoprost (brand name Xalatan) the most commonly prescribed drug.
Glaucoma Drug Forecast and Market research: Glaucoma is a leading cause of preventable blindness globally. This chronic progressive optic neuropathy causes irreversible vision loss through damage to the optic nerve. There are currently no treatments that can directly prevent this damage, and all commercially available glaucoma therapies focus on lowering elevated intraocular pressure (IOP), a known risk factor for glaucoma development and progression. The launch of fixed-dose combination (FDC) products, which combine drugs from these various classes, will continue to be a source of significant growth in this market. The glaucoma market is about to enter a phase of new growth with the arrival of first-in-class drugs, such as Aerie's Rhopressa, Bausch & Lomb's Vesneo (latanoprost bunod), and Inotek's trabodenoson into the 7MM during the forecast period, which will generate additional growth in the global glaucoma market.
Market Growth of Advertising and Marketing:
Figure : No. of conferences related to eye
Source: Reference 8
Fund Allotment to Eye Treatments and Research:
The treatment market for glaucoma will rise in value from $2.4 billion in 2013 to approximately $3 billion by 2023 across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, UK, and Japan, representing a moderate overall Compound Annual Growth Rate (CAGR) of 2.4%, says research and consulting firm GlobalData.
The company’s latest report* states that growth will be driven by the arrival of innovative first-in-class drugs, such as Rhopressa/Roclatan, Vesneo, and trabodenoson, and the introduction of additional fixed-dose combination (FDC) products, such as Tapcom/Taptiqom and Simbrinza, during the forecast period.
Importance & Scope:
Overview of glaucoma, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
– Annualized Glaucoma market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023.
– Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the glaucoma therapeutics market.
– Pipeline analysis: focus on the eight late-stage pipeline glaucoma drugs discussing emerging trends as well as overview of earlier phase drugs.
– Analysis of the current and future market competition in the global glaucoma therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Why Kuala Lumpur:
Malaysia’s capital is quickly establishing itself as one of Southeast Asia’s leading study destinations. The rapidly improving reputation of Malaysia’s higher education sector, headed by Universiti Malaya (now ranked 146th in the world) reflects the wider coming to prominence of the country itself on the world stage.
Major Associations around the Globe related to Eye:
American Glaucoma Society
British Columbia Association of Optometrists
American Glaucoma Society
World Glaucoma Association
International Glaucoma Association
Glaucoma Australia
Glaucoma Research Society of Canada
National Eye Institute - Glaucoma Information in Spanish
Optometric Glaucoma Society
South East Asia Glaucoma Interest Group (SEAGIG)
World Glaucoma Patient Association
American Optometric Association
Asia-Pacific Glaucoma Society (APGS)
Asia-pacific Association of Cataract and Refractive Surgeon
World Association of Eye Hospitals
International Opticians Association
Major Associations related to Eye in Malaysia:
Association of Malaysian Optometrists (AMO)
Malaysian Association for the Blind
Malaysia Glaucoma Society
Malaysian Pharmaceutical Society
Malaysian Society of Ophthalmology
Malaysian Association for the Blind and Blindness
Association of Vision Science Librarians
Statistical Analysis of Associations:
Figure : Statistical Analysis of Eye Associations
Source: Reference-1
Target Audience:
Ophthalmologist, researchers, eye surgeons, physicians, eye care specialists, professors, scientific community, delegates and students are the main participants for the conference. Business professionals (Directors, presidents, CEO) from eye equipment companies.
Graphical Representation of the Target Audience:
Eye Surgeons/Doctors : 50%
Researcher/ Professors: 30%
Business/ Marketing Eye Equipments : 20 %
Figure 2:Target Audience
Source:Reference-2
Top Universities in Kuala Lumpur:
University of Malaysia
International Islamic University Malaysia
International Medical University
HELP University
UCSI University
University of Kuala Lumpur
Asia e University
Universiti Tun Abdul Razak
Figure: Top Universities in Kuala Lumpur
Source:Reference 3
Top Hospitals for Eye Treatments:
Tun Hussein On National Eye Hospital
JMC Specialist Eye Centre
International Specialist Eye Centre
Optimax Eye Specialist Centre
Eye Laser Correction
Chew Eye Specialist & Surgery
New Hope Medic
Angeline Eye Specialist & Laser Centre
At Sun Time Optometry
USJ Eye Specialist
Mata Clinic & Optometrist
Subspecialist Eye Associates
KL Eye Specialist Centre
Normah Medical Specialist Centre
Eye Specialist Centre Kuching
Stasticial Representation of Top Hospitals for Eye Treatment:
Figure : Hospitals for Eye Treatment
Source:Reference 5
Statistics of future projection of Marketers, Researchers and Academicians working on Eye and vision:
Figure : People
Reference:
Conference Highlights
- Causes of Glaucoma
- Symptoms and Diagnosis of Glaucoma
- Treatments for Glaucoma
- Medications for Glaucoma
- Primary Glaucoma
- Secondary Glaucoma
- Retina Disorders during Glaucoma
- Pediatric Glaucoma
- Surgical Techniques in Glaucoma
- Novel therapeutics ways for treating Glaucoma
- Future of glaucoma treatment
- Glaucoma Management
- Eye-Sight and Vision: An Overview
- Ophthalmologists Career & Training
- Optometrists Courses & Education
- Cornea and Corneal Disease
- Retina and Retinal Disorders
- Neuro-Ophthalmology and Research
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
| Conference Date | October 13-15, 2016 | ||
| Sponsors & Exhibitors |
|
||
| Speaker Opportunity Closed | Day 1 | Day 2 | Day 3 |
| Poster Opportunity Closed | Click Here to View | ||
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
Abstracts will be provided with Digital Object Identifier by
